IE
KURA icon

Israel Englander’s Kura Oncology KURA Stock Holding History

Israel Englander’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.8M Sell
711,332
-853,811
-55% -$8.06M ﹤0.01% 2560
2026
Q1 		$12.7M Sell
1,565,143
-19,256
-1% -$165K 0.01% 1944
2025
Q4 		$16.5M Sell
1,584,399
-509,303
-24% -$5.34M 0.01% 1755
2025
Q3 		$18.5M Sell
2,093,702
-527,820
-20% -$3.76M 0.01% 1747
2025
Q2 		$15.1M Buy
2,621,522
+811,983
+45% +$4.97M 0.01% 1849
2025
Q1 		$11.9M Sell
1,809,539
-557,609
-24% -$4.35M 0.01% 2000
2024
Q4 		$20.6M Buy
2,367,148
+1,521,954
+180% +$21.9M 0.01% 1492
2024
Q3 		$16.5M Buy
845,194
+505,712
+149% +$10.2M 0.01% 1729
2024
Q2 		$6.99M Sell
339,482
-148,734
-30% -$3.06M ﹤0.01% 2394
2024
Q1 		$10.4M Buy
488,216
+355,726
+268% +$6.92M ﹤0.01% 2150
2023
Q4 		$1.91M Sell
132,490
-49,940
-27% -$491K ﹤0.01% 3650
2023
Q3 		$1.66M Sell
182,430
-213,741
-54% -$2.17M ﹤0.01% 3731
2023
Q2 		$4.19M Buy
396,171
+374,981
+1,770% +$4.43M ﹤0.01% 2818
2023
Q1 		$259K Sell
21,190
-35,636
-63% -$445K ﹤0.01% 5014
2022
Q4 		$705K Sell
56,826
-407,629
-88% -$5.93M ﹤0.01% 4472
2022
Q3 		$6.34M Buy
464,455
+401,725
+640% +$6.2M ﹤0.01% 2662
2022
Q2 		$1.15M Sell
62,730
-93,267
-60% -$1.34M ﹤0.01% 4240
2022
Q1 		$2.51M Sell
155,997
-95,765
-38% -$1.38M ﹤0.01% 3654
2021
Q4 		$3.52M Buy
251,762
+151,149
+150% +$2.45M ﹤0.01% 3229
2021
Q3 		$1.88M Sell
100,613
-291,202
-74% -$5.49M ﹤0.01% 4000
2021
Q2 		$8.17M Buy
391,815
+66,711
+21% +$1.66M 0.01% 2154
2021
Q1 		$9.19M Buy
325,104
+117,192
+56% +$3.71M 0.01% 1878
2020
Q4 		$6.79M Buy
+207,912
New +$7.31M ﹤0.01% 2154
2020
Q3 		– Sell
-164,857
Closed -$2.69M – 4656
2020
Q2 		$2.69M Sell
164,857
-315,861
-66% -$4.56M ﹤0.01% 2314
2020
Q1 		$4.78M Sell
480,718
-149,009
-24% -$1.71M 0.01% 1360
2019
Q4 		$8.66M Buy
+629,727
New +$9.33M 0.01% 1495
2019
Q3 		– Sell
-96,943
Closed -$1.91M – 4377
2019
Q2 		$1.91M Buy
96,943
+84,421
+674% +$1.4M ﹤0.01% 2434
2019
Q1 		$208K Sell
12,522
-12,330
-50% -$190K ﹤0.01% 3716
2018
Q4 		$349K Sell
24,852
-417,095
-94% -$5.53M ﹤0.01% 3152
2018
Q3 		$7.73M Sell
441,947
-82,925
-16% -$1.59M 0.01% 1492
2018
Q2 		$9.55M Buy
524,872
+2,661
+0.5% +$45.1K 0.01% 1345
2018
Q1 		$9.79M Buy
522,211
+218,306
+72% +$4.25M 0.01% 1342
2017
Q4 		$4.65M Buy
303,905
+79,989
+36% +$1.18M 0.01% 1770
2017
Q3 		$3.35M Buy
+223,916
New +$2.1M 0.01% 1883
2017
Q2 		– Sell
-40,382
Closed -$355K – 3669
2017
Q1 		$355K Buy
+40,382
New +$296K ﹤0.01% 2974

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Israel Englander's KURA Position: Q2 2026 in Review

Israel Englander reduced its Kura Oncology (KURA) stake by 55% in Q2 2026, selling an estimated $8.06M and leaving 711,332 shares worth $7.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

Israel Englander first reported a position in KURA in Q1 2017 and has held it in 35 quarters since. The position peaked at $20.6M in Q4 2024. 219 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Israel Englander held 711,332 shares of Kura Oncology worth $7.8M as of Q2 2026.
  • Israel Englander sold 853,811 Kura Oncology shares in Q2 2026, an estimated $8.06M.
  • Kura Oncology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2560 holding.
  • Israel Englander first reported a position in Kura Oncology in Q1 2017 and has held it in 35 quarters since.
  • Israel Englander's Kura Oncology position peaked at $20.6M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.